Medtronic Painkiller Pump Recalled for Defective Batteries

Medtronic’s SynchroMed II implantable painkiller pump has been recalled.  This is the second class 1 recall this year due to reports of defective batteries.   Medtronic’s urgent update last month became a second class I recall for its SynchroMed II implantable drug infusion pumps because of reports that the devices may have defective batteries that can lead to sudden failure.

The SynchroMed system includes an implanted catheter and pump infusion system that stores and delivers medication to a specific site. There are about 140,000 pumps in use worldwide. There have now been 55 confirmed cases of battery defects resulting in device failure as of May 31, 2011.

The problem is caused by the formation of a filmy substance within the pump battery that led the devices to shut down suddenly, causing a patient’s pain and symptoms to return or triggering withdrawal symptoms.   The FDA has approved a battery design change intended to prevent the issue from occurring in new pumps, and all SynchroMed II pumps are being manufactured with the new battery and the design change has already been implemented in several global regions and is in the process of being implemented in the rest.

Class 1 recalls are considered the most serious type of recall, reserved for situations with a reasonable probability of serious adverse consequences or death.

FDA Recall Warning: http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm271510.htm

Company information for recall:  Medtronic Issues Communication about the Potential for Reduced Battery Performance in a Small Percentage of SynchroMed® II Implantable Drug Infusion Pumps

About The Author

Laura Hack

Laura Hack

Laura Hack is a paralegal with Terrell • Hogan. She has been with the firm since 1996 and has worked primarily for Wayne Hogan. She is an experienced Paralegal with 30+ years of working in the law practice industry. Skilled in Appeals, Civil Trial Litigation Support, Torts, Trial Practice, and Pleadings.